T Frebourg
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
-
- Cancer Research and Treatments 2
- Oncology 6
- Cancer-related Molecular Pathways 6
- Co-authors
- François WaridelStephen FriendRichard IggoJean‐Michel FlamanAnne EstreicherJ KasselLuc BronC Fontolliet
- Journals
- European Journal of Endocrinology (1 paper)Oncogene (1 paper)Proceedings of the National Academy of Sciences (1 paper)PubMed (5 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
T Frebourg
8 papers receiving 445 citations
Peers
Comparison fields: 5 of 46
- Oncology 312
- Otorhinolaryngology 40
- Biotechnology 72
- Cancer Research 93
- Molecular Biology 268
Countries citing papers authored by T Frebourg
This map shows the geographic impact of T Frebourg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Frebourg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Frebourg more than expected).
Fields of papers citing papers by T Frebourg
This network shows the impact of papers produced by T Frebourg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Frebourg. The network helps show where T Frebourg may publish in the future.
Co-authorship network
The 22 scholars most cited alongside T Frebourg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 39 | |
| 2 | 1997 | 160 | |
| 3 | The human tumour suppressor gene p53 is alternatively spliced in normal cells. | 1996 | 75 |
| 4 | Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype. | 1994 | 43 |
| 5 | 1992 | 76 | |
| 6 | A functional screen for germ line p53 mutations based on transcriptional activation. | 1992 | 59 |
| 7 | Cancer risks from germ line tumor suppressor gene mutations. | 1991 | 2 |
| 8 | [Hyaluronic acid. Usefulness and perspectives of its serum assay]. | 1990 | 1 |
About T Frebourg
T Frebourg is a scholar working on Biotechnology, Oncology, Ophthalmology, Molecular Biology and Neurology, having authored 8 papers that have together received 455 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (2 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Myasthenia Gravis and Thymoma (1 paper), Fibroblast Growth Factor Research (1 paper), Hedgehog Signaling Pathway Studies (1 paper) and Adrenal Hormones and Disorders (1 paper). The work is most often cited by research in Oncology (312 citations), Otorhinolaryngology (40 citations), Biotechnology (72 citations), Cancer Research (93 citations) and Molecular Biology (268 citations). T Frebourg has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include François Waridel, Stephen Friend, Richard Iggo, Jean‐Michel Flaman, Anne Estreicher, J Kassel, Luc Bron, C Fontolliet, Yin‐Shan Ng and A L Børresen. Their work appears in journals such as European Journal of Endocrinology, Oncogene, Proceedings of the National Academy of Sciences and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.